Home/Filings/4/0001464104-12-000002
4//SEC Filing

Rios Israel 4

Accession 0001464104-12-000002

CIK 0000880771other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:15 PM ET

Size

11.1 KB

Accession

0001464104-12-000002

Insider Transaction Report

Form 4
Period: 2012-03-13
Rios Israel
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2012-03-13$1.08/sh+48,750$52,65073,750 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2012-03-1348,75016,250 total
    Exercise: $1.08Exp: 2019-03-06Common Stock (48,750 underlying)
Footnotes (2)
  • [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
  • [F2]25% of such shares vest one year from the date of grant, of March 6, 2009, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

Entity typeother

Related Parties

1
  • filerCIK 0001464104

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:15 PM ET
Size
11.1 KB